Phasic Treatment with Interferon Gamma Stimulates Release of Exosomes that Protect Against Spreading Depression

Journal of Interferon and Cytokine Research

Volumn 35, Issue 10, 2015, Pages 795-807

  Pusic, Aya D ^a   Kraig, Richard P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; ARGININE; CD32 ANTIGEN; GLUTATHIONE; INTERLEUKIN 10; MICRORNA; MYELIN; MYELIN BASIC PROTEIN; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RESPONSE; DENTATE GYRUS; EXOSOME; FEMALE; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL SLICE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MYELINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SPREADING CORTICAL DEPRESSION; ANIMAL; CELL CULTURE; DEPRESSION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; OXIDATIVE STRESS; TISSUE CULTURE TECHNIQUE;

ANIMALS; CELLS, CULTURED; DEPRESSION; DISEASE MODELS, ANIMAL; EXOSOMES; GENE EXPRESSION PROFILING; GLUTATHIONE; HIPPOCAMPUS; INTERFERON-GAMMA; MICROGLIA; MICRORNAS; OXIDATIVE STRESS; RATS; TISSUE CULTURE TECHNIQUES;

EID: 84942906020     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2015.0010     Document Type: Article

References (64)

1. Balabanov R, Strand K, Goswami R, McMahon E, Begolka W, Miller SD, Popko B. 2007. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J Neurosci 27(8):2013-2024.
2. Baron R, Nemirovsky A, Harpaz I, Cohen H, Owens T, Monsonego A. 2008. IFN-gamma enhances neurogenesis in wildtype mice and in a mouse model of Alzheimer's disease. FASEB J 22(8):2843-2852.
3. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA, Locati M. 2009. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A 106(13):5282-5287.
4. Bobrie A, Colombo M, Raposo G, Théry C. 2011. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12(12):1659-1668.
5. Budde H, Schmitt S, Fitzner D, Opitz L, Salinas-Riester G, Simons M. 2010. Control of oligodendroglial cell number by the miR-17-92 cluster. Development 137(13):2127-2132.
6. Caggiano AO, Kraig RP. 1998. Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1beta production in cultured rat microglia. J Neurochem 70(6):2357-2368.
7. Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, Mattson MP. 2007. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222(1):122-128.
8. Chakraborty G, Ziemba S, Drivas A, Ledeen RW. 1997. Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha. J Neurosci Res 50(3):466-476.
9. Chen Q, Xu J, Li H, Mao S, Zhang F, Zen K, Zhang CY, Zhang Q. 2014. MicroRNA-23a/b and microRNA-271/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis 5:e1132.
10. Darabaneanu S, Overath CH, Rubin D, Lüthje S, Sye W, Niederberger U, Weisser B. 2011. Aerobic exercise as a therapy option for migraine: A pilot study. Int J Sports Med 32(6): 455-460.
11. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Barres BA. 2010. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65(5):597-611.
12. Eder C, Schilling T, Heinemann U, Haas D, Hailer N, Nitsch R. 1999. Morphological, immunophenotypical and electrophysiological properties of resting microglia in vitro. Eur J Neurosci 11(12):4251-4261.
13. Eldh M, Ekström K, Valadi H, Sjöstrand M, Olsson B, Jernas M, Lötvall J. 2010. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PloS One 5(12):e15353.
14. Espejo C, Penkowa M, Saez-Torres I, Hildalgo J, Garcia A, Montalban X, Martinez-Cáceres EM. 2002. Interferongamma regulates oxidative stress during experimental autoimmune encephalomyelitis. Exp Neurol 177(1):21-31.
15. Fields RD. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31(7):361-370.
16. Frei K, Bodmer S, Schwerdel C, Fontana A. 1986. Astrocytederived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J Immunol 137(11):3521-3527.
17. Gao X, Gillig TA, Ye P, D'Ercole AJ, Matsushima GK, Popko B. 2000. Interferon-gamma protects against cuprizoneinduced demyelination. Mol Cell Neurosci 16(4):338-349.
18. Gidday JM. 2006. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7(6):437-448.
19. Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP. 2013. Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-alpha responses to spreading depression. J Neurochem 126:662-672.
20. Grinberg YY, van Drongelen W, Kraig RP. 2012. Insulin-like growth factor-1 lowers spreading depression susceptibility and reduces oxidative stress. J Neurochem 122(1):221-229.
21. Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide-and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur J Neurosci 16(11): 2113-2122.
22. Hayakawa K, Okazaki R, Morioka K, Nakamura K, Tanaka S, Ogata T. 2014. Lipopolysaccharide preconditioning facilitates M2 activation of resident microglia after spinal cord injury. J Neurosci Res 92(12):1647-1658.
23. Hulse RE, Swenson WG, Kunkler PE, White DM, Kraig RP. 2008. Monomeric IgG is neuroprotective via enhancing microglial recycling endocytosis and TNF-alpha. J Neurosci 28(47):12199-12211.
24. Jana A, Pahan K. 2007. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol 2(2): 184-193.
25. Jana A, Pahan K. 2010. Sphingolipids in multiple sclerosis. Neuromol Med 12(4):351-361.
26. Karikó K, Weissman D, Welsh FA. 2004. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24(11):1288-1304.
27. Kraig RP, Dong LM, Thisted R, Jaeger CB. 1991. Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein. J Neurosci 11(7):2187-2198.
28. Kraig RP, Mitchell HM, Christie-Pope B, Kunkler PE, White DM, Tang YP, Langan G. 2010. TNF-a and microglial hormetic involvement in neurological health and migraine. Dose Response 8(4):389-413.
29. Kunkler PE, Kraig RP. 2003. Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus 13(7):835-844.
30. Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L, Hudson LD. 2008. Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci 28(45):11720-11730.
31. Lauritzen M, Kraig RP. 2005. Spreading depression and migraine. In: Olesen J, Goadsby P, Ramadan N, Tfelt-Hansen A, Welch KMA, eds. The headaches, 3rd ed. Philadelphia, PA: Lippencott-Raven. pp. 269-267.
32. Leao AAP. 1944. Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359-390.
33. Lee J, Kim SJ, Son TG, Chan SL, Mattson MP. 2006. Interferongamma is up-regulated in the hippocampus in response to intermittent fasting and protects hippocampal neurons against excitotoxicity. J Neurosci Res 83(8):1552-1557.
34. Lee JJ, Drakaki A, Iliopoulos D, Struhl K. 2012. MiR-27b targets PPARg to inhibit growth, tumor progression, and the inflammatory response in neuroblastoma cells. Oncogene 31(33):3818-3825.
35. Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, Popko B. 2007. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 117(2):448-456.
36. Lin W, Harding HP, Ron D, Popko B. 2005. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 169(4):603-612.
37. Lin W, Kunkler PE, Harding HP, Ron D, Kraig RP, Popko B. 2008. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferongamma. Am J Pathol 173(5):1508-1517.
38. Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, Hannun YA. 1998. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273(18):11313-11320.
39. Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH. 2001. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci 187(1-2):91-97.
40. Mack KL. 2011. Can we help patients with chronic migraine? Neurology 76:682-683.
41. Mandavilli BS, Janes MS. 2010. Detection of intracellular glutathione using ThiolTracker violet stain and fluorescence microscopy. Curr Protoc Cytom Chapter 9:Unit 9. 35.
42. Mattson MP. 2008. Hormesis defined. Ageing Res Rev 7(1): 1-7.
43. Moskowitz MA, Nozaki K, Kraig RP. 1993. Neocortical spreading depression provokes the expression of c-fos proteinlike immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13(3):1167-1177.
44. Mü ller M, Fontana A, Zbinden G, Gähwiler BH. 1993. Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures. Brain Res 619(1-2): 157-162.
45. Nikolova-Karakashian M, Karakashian A, Rutkute K. 2008. Role of neutral sphingomyelinases in aging and inflammation. Subcell Biochem 49:469-486.
46. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45.
47. Pusic AD, Grinberg YY, Mitchell HM, Kraig RP. 2011. Modeling neural immune signaling of episodic and chronic migraine using spreading depression in vitro. J Vis Exp (52):pii: 2910.
48. Pusic AD, Kraig RP. 2014. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination. Glia 62(2):284-299.
49. Pusic AD, Mitchell HM, Kunkler PE, Klauer N, Kraig RP. 2015. Spreading depression transiently disprupts myelin via interferon-gamma signaling. Exp Neurol 264:43-54.
50. Pusic AD, Pusic KM, Clayton BLL, Kraig RP. 2014a. IFNgstimulated dendritic cell exosomes as a potential therapeutic for remyelination. J Neuroimmunol 266(1-2):12-23.
51. Pusic KM, Pusic AD, Kemme J, Kraig RP. 2014b. Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment. Glia 62(7): 1176-1194.
52. Radak Z, Chung HY, Goto S. 2008. Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med 44(2):153-159.
53. Rasmussen BK, Jensen R, Olesen J. 1991. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 11(3):129-134.
54. Rutkute K, Asmis RH, Nikolova-Karakashian MN. 2007. Regulation of neutral sphingomyelinase-2 by GSH: A new insight to the role of oxidative stress in aging-associated inflammation. J Lipid Res 48(11):2443-2452.
55. Sievers J, Parwaresch R, Wottge HU. 1994. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: morphology. Glia 12(4):245-258.
56. Stenzel-Poore MP, Stevens SL, King JS, Simon RP. 2007. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuropro-tective phenotypes: A speculative synthesis. Stroke 38(2 Suppl): 680-685.
57. Soreq H, Wolf Y. 2011. NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol Med 17(10):548-555.
58. Tabatadze N, Savonenko A, Song H, Bandaru VVR, Chu M, Haughey NJ. 2010. Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice. J Neurosci Res 88(13):2940-2951.
59. Wang CY, Yang SH, Tzeng SF. 2015. MicroRNA-145 as one negative regulator of astrogliosis. Glia 63:194-205.
60. Yanovsky Y, Brankack J, Haas HL. 1995. Differences of CA3 bursting in DBA/1 and DBA/2 inbred mouse strains with divergent shuttle box performance. Neuroscience 64(2):319-325.
61. Zhao YY, Shi XY, Qiu X, Lu W, Yang S, Li C, Tang Y. 2012. Enriched environment increases the myelinated nerve fibers of aged rat corpus callosum. Anat Rec (Hoboken) 295(6): 999-1005.
62. Zhu PJ, Huang W, Kalikulov D, Yoo JW, PLaczek AN, Stoica L, Zhou H, Bell JC, Friedlander MJ, Krnjevic K, Noebels JL, Costa-Mattioli M. 2011. Suppression of PKR promotes network excitability and enhanced cognition by interferon-gmediated disinhibition. Cell 147(6):1384-1396.
63. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Schwartz M. 2006. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9(2):268-275.
64. Zolad PR, Diamond DM. 2008. Linear and non-linear doseresponse functions reveal a hormetic relationship between stress and learning. Dose Response 7(2):132-148.